Sort
10,766 grants matching “checkpoint inhibitor”
Mouse Models of Tumor Progression and Therapy Response
$364,978Christopher J Kemp · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
Project 1: Priming and propagating immunity against head and neck cancer using targeted radionuclide therapy
$364,957Zachary Scott Morris · University Of Wisconsin-Madison · P50 · FY2023 · CA
Mechanisms of Intestinal Tumorigenesis
$364,946Vincent W. Yang · State University New York Stony Brook · R01 · FY2014 · CA
RNase H2 is a novel therapeutic target in triple negative breast cancer
$364,910Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Mechanism of double-negative T cells in antitumor immunity to breast cancer
$364,880Hui Zhang · Washington State University · R01 · FY2023 · CA
The Pancreatic Cancer Microenvironment
$364,845Rui Kang · Ut Southwestern Medical Center · R01 · FY2022 · CA
Role of exosomal SPHK1 in ovarian cancer progression
$364,802Sunila Pradeep · Medical College Of Wisconsin · R01 · FY2023 · CA
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$364,720Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2024 · NS
Project 3: Targeting Bax signaling to overcome treatment resistance in NSCLC
$364,713Xingming Deng · Emory University · P50 · FY2022 · CA
Expanding the Therapeutic Window of Nanoparticle STING Agonists for Cancer Immunotherapy
$364,644John Tanner Wilson · Vanderbilt University · R01 · FY2022 · CA
Platinum-induced lipid reprogramming and tumor immune microenvironment in SCLC
$364,593Lingtao Jin · University Of Texas Hlth Science Center · R01 · FY2022 · CA
Immunological, serologic, and imaging biomarker predictors of flare in pediatric spondyloarthritis
$364,553Pamela Fitch Weiss · Children'S Hosp Of Philadelphia · R01 · FY2025 · AR
Transcriptional mechanisms and melanoma
$364,462Leonard I Zon · Massachusetts General Hospital · P01 · FY2020 · CA
Transcriptional mechanisms and melanoma
$364,460Leonard I Zon · Massachusetts General Hospital · P01 · FY2021 · CA
Project 2: Neo-antigen Vaccines for Pancreatic and Colorectal Cancers
$364,385Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2018 · CA
Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer
$364,378King Kwong · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
$364,342David E Fisher · Massachusetts General Hospital · R01 · FY2017 · AR
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
$364,342David E Fisher · Massachusetts General Hospital · R01 · FY2020 · AR
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
$364,342David E Fisher · Massachusetts General Hospital · R01 · FY2019 · AR
Defining the determinants of response and resistance to therapy for Richter's Syndrome
$364,213Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Core B: Clinical Core
$364,178Arthur Y Kim · Massachusetts General Hospital · U19 · FY2024 · AI
Molecular Mechanisms of Replication Stress Response
$364,140Huzefa Mannan Dungrawala · University Of South Florida · R35 · FY2021 · GM
Molecular Mechanisms of Replication Stress Response
$364,140Huzefa Mannan Dungrawala · University Of South Florida · R35 · FY2024 · GM
Molecular Mechanisms of Replication Stress Response
$364,140Huzefa Mannan Dungrawala · University Of South Florida · R35 · FY2023 · GM
Molecular Mechanisms of Replication Stress Response
$364,140Huzefa Mannan Dungrawala · University Of South Florida · R35 · FY2022 · GM